Previous 10 | Next 10 |
2024-01-09 09:25:51 ET More on Illumina Illumina: The Divestiture Of Grail Could Unlock Significant Shareholder Value Illumina: Conditions Are Met For A Rebound Illumina, Inc. (ILMN) Piper Sandler 35th Annual Healthcare Conference (Transcript) It's JPM time! ...
Illumina Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2023 PR Newswire SAN DIEGO , Jan. 9, 2024 /PRNewswire/ -- Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced unaudited preliminary financial results for t...
2024-01-09 07:05:00 ET Shares of gene sequencing leader Illumina (NASDAQ: ILMN) rallied 36.6% in December, according to data from S&P Global Market Intelligence . Investors might not be quite so excited, as Illumina entered the month more than 80% below its all-time high...
2024-01-07 17:18:52 ET More on Akoya Biosciences, Exact Sciences, etc. Guardant Health: Vast Market Opportunity, Challenging Valuation Illumina: The Divestiture Of Grail Could Unlock Significant Shareholder Value Illumina: Conditions Are Met For A Rebound Nan...
Illumina expands collaboration with Janssen to advance molecular residual disease cancer test PR Newswire SAN DIEGO , Jan. 5, 2024 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced it has...
Illumina to Announce Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 8, 2024 PR Newswire SAN DIEGO , Jan. 4, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that it will issue results for the fourth quarter and fu...
The Alliance for Genomic Discovery welcomes Bristol Myers Squibb, GSK, and Novo Nordisk PR Newswire AGD delivered ~86,000 whole genomes in 2023, including a unique diverse ancestry cohort Expanded pharma engagement enhances AGD's ability to develop multiomic datas...
2024-01-03 04:30:00 ET Summary The Ensemble Fund seeks to achieve long-term capital appreciation. The Fund invests in a focused portfolio of approximately 15 to 30 securities that meet our demanding criteria. The Ensemble Fund returned 3.32% for the fiscal year, underperforming th...
2023-12-29 14:13:44 ET More on Standard BioTools, SomaLogic, etc. SomaLogic Inc. (SLGC) Q3 2023 Earnings Call Transcript Standard BioTools Inc. 2023 Q3 - Results - Earnings Call Presentation Standard BioTools Inc. (LAB) Q3 2023 Earnings Call Transcript SomaLo...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Illumina To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 investing in Illumina securities between August 18, 2021 and October 16, 2023 and...
News, Short Squeeze, Breakout and More Instantly...
Illumina to Present Upcoming Strategy Update PR Newswire SAN DIEGO , July 18, 2024 /PRNewswire/ -- As Illumina, Inc. (NASDAQ: ILMN) previously announced on June 24 , the company will present a Strategy Update on Tuesday, August 13, 2024 starting at ...
Illumina to Announce Second Quarter 2024 Financial Results on Tuesday, August 6, 2024 PR Newswire SAN DIEGO , July 11, 2024 /PRNewswire/ -- As Illumina, Inc. (NASDAQ:ILMN) previously announced on June 24 , the company will issue results for the second qu...
The Illumina iHope China program will provide 1800 families with genetic testing in 2024, broadening its reach and impact nationwide Originally published on Illumina News Center NORTHAMPTON, MA / ACCESSWIRE / July 11, 2024 / This year may be the most impactful yet in the short history o...